About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: January 2007
Medicare Part D Reform – Part 2
Everyone is interested in the new bill before Congress on Medicare and the ability of the government to negotiate prices. For those unaware of this issue, a controversial aspect of Medicare Part D was that it left the government without … Continue reading
Posted in Current Affairs
Comments Off on Medicare Part D Reform – Part 2
The News on the News
Since there was so little activity this week given the holiday and the Ford funeral, there is no Weekly Roundup today. But I took the opportunity to do something I’ve wanted to do for a long time. Longtime readers will … Continue reading
Posted in DTC Advertising
1 Comment
The New Congress
Well, today the new Congress hits town. They will be shown their lockers, roll call will be taken and the bell will ring and instruction will begin. There will be lots of photos. Final touches will be put on offices, … Continue reading
Posted in Current Affairs
Comments Off on The New Congress
A Taste of the Familiar – Cloning, Labeling and FDA Image
I have written in the past on the issue of animal cloning and the food supply (See – Send in the Clones, October 17, 2006) but the recent action by FDA putting out a issues drafts on animal cloning means … Continue reading
Posted in FDA Image, FDA Policy, Food
1 Comment